BIOHAVEN LTD (BHVN)
VGG1110E1079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 248.40M | 204.90M | 76.10M | 82.50M | 316.70M | |||
| Marketable Securities | 133.42M | 260.50M | 192.65M | 223.20M | N/A | |||
| Receivables | 13.65M | 46.10M | 308.27M | 120.10M | 3.00M | |||
| Inventories | N/A | N/A | 80.61M | 39.60M | N/A | |||
| Other Current Assets | 46.98M | 75.40M | 18.70M | 7.20M | 8.60M | |||
| Total Current Assets | 442.45M | 587.00M | 94.80M | 89.80M | 328.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 48.58M | 52.40M | 13.00M | 7.60M | 8.20M | |||
| Investments And Advances | N/A | N/A | 0.00 | 1.20M | 5.30M | |||
| Goodwill | 1.39M | 1.40M | 1.40M | 0.00 | N/A | |||
| Intangibles | 18.40M | 18.40M | 18.40M | 0.00 | N/A | |||
| Other Non-Current Assets | 2.40M | 2.60M | 14.40M | 13.00M | 2.50M | |||
| Total Non-Current Assets | 70.77M | 74.80M | 47.30M | 21.70M | 16.00M | |||
| TOTAL ASSETS | 513.21M | 661.80M | 142.10M | 111.50M | 344.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 5.41M | 5.60M | N/A | |||
| Accrued Expenses | 39.85M | 44.10M | 37.20M | 27.10M | 52.10M | |||
| Accounts Payable | 15.58M | 10.70M | 4.80M | 2.80M | 14.10M | |||
| Other Current Liabilities | 0.00 | 35.20M | 84.53M | 62.50M | N/A | |||
| Total Current Liabilities | 55.42M | 90.00M | 41.90M | 29.90M | 66.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 247.80M | |||
| Other Non-Current Liabilities | 29.81M | 33.00M | 5.40M | 4.80M | 37.80M | |||
| Total Non-Current Liabilities | 29.81M | 33.00M | 65.50M | 64.80M | 285.50M | |||
| TOTAL LIABILITIES | 85.24M | 123.00M | 107.40M | 94.70M | 351.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -499.29M | -91.10M | -2.59B | -1.74B | -972.40M | |||
| Additional Paid In Capital | 39.80M | 13.90M | 169.66M | 98.90M | 83.50M | |||
| Minority Interest | N/A | 0.00 | 61.81M | 61.82M | N/A | |||
| Common Shares | 887.53M | 615.70M | 1.68B | 1.25B | 881.40M | |||
| Other Shareholders' Equity | -65.00K | 300.00K | 34.70M | 16.80M | N/A | |||
| Shares Outstanding | 81.12M | 68.20M | 64.40M | 64.40M | 52.40M | |||
| Tangible Book Value per Share | 5.03 | 7.61 | 0.23 | 0.26 | -0.14 | |||
| Total Shareholders' Equity | 427.98M | 538.80M | 34.70M | 16.80M | -7.40M | |||
| TOTAL LIABILITIES AND EQUITY | 513.21M | 661.80M | 142.10M | 111.50M | 344.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -33.49 | |||
| Current Ratio | 7.98 | 6.52 | 2.26 | 3.00 | 4.96 | |||
| Return On Assets (ROA) | -79.53% | -86.17% | -150.46% | -106.43% | -153.59% | |||
| Return On Equity (ROE) | -95.37% | -105.84% | -616.14% | -706.37% | N/A | |||
All data in USD